COM:MUSTANGBIO
Mustang Bio
- Stock
Last Close
0.35
26/07 20:00
Market Cap
15.08M
Beta: -
Volume Today
1.12M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||
average payables | 349K - | 2.15M 515.19% | 4.61M 114.90% | 4.04M 12.33% | 5.86M 44.75% | 9.85M 68.27% | 12.48M 26.70% | 7.25M 41.93% | ||
average receivables | 53K - | 71.50K 34.91% | 28K 60.84% | 17K 39.29% | 32.50K 91.18% | 43K 32.31% | 1.96M 4,452.33% | |||
book value per share | 13.88 - | 35.54 156.02% | 20.26 43.00% | 21.48 6.06% | 28.08 30.68% | 19.18 31.67% | 6.71 65.02% | 0.00 100.00% | ||
capex per share | -1.66 - | -4.42 165.98% | -1.54 65.24% | -1.26 18.12% | -0.92 27.22% | -0.45 51.25% | -0.00 100.00% | |||
capex to depreciation | -1.40K - | -12.61 99.10% | -2.70 78.58% | -2.47 8.49% | -2.33 5.86% | -1.02 56.35% | -0.03 97.17% | |||
capex to operating cash flow | 0.22 - | 0.41 90.98% | 0.11 73.35% | 0.12 7.44% | 0.10 15.43% | 0.05 52.67% | 0.00 97.27% | |||
capex to revenue | ||||||||||
cash per share | 15.72 - | 36.22 130.34% | 18.97 47.64% | 25.54 34.69% | 27.90 9.21% | 18.71 32.93% | 10.97 41.36% | 0.00 99.99% | ||
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | ||||||||||
debt to assets | 0.01 - | 0.21 - | 0.02 90.41% | 0.02 19.88% | 0.34 1,990.59% | 0.14 58.53% | ||||
debt to equity | -0.86 - | 0.01 101.52% | 0.30 - | 0.02 92.47% | 0.02 20.09% | 0.68 3,649.57% | 20.31 2,894.57% | |||
dividend yield | 0.00 - | 0.00 - | ||||||||
earnings yield | -0.05 - | -0.10 109.93% | -0.39 274.50% | -0.33 15.43% | -0.31 4.61% | -0.44 40.69% | -1.93 339.25% | -0.00 99.77% | ||
enterprise value | 3.57M - | 229.90M 6,337.86% | 267.81M 16.49% | 62.76M 76.56% | 101.25M 61.32% | 103.49M 2.21% | 38.30M 62.99% | -3.38M 108.83% | 11.61B 343,274.58% | |
enterprise value over ebitda | -20.26 - | -8.56 57.74% | -2.09 75.59% | -2.34 11.98% | -1.84 21.19% | -0.58 68.71% | 0.05 107.90% | -235.72 516,784.65% | ||
ev to operating cash flow | -55.68 - | -20.68 62.85% | -3.26 84.23% | -3.02 7.55% | -2.77 8.02% | -0.71 74.26% | 0.05 107.29% | -234.69 451,400.55% | ||
ev to sales | ||||||||||
free cash flow per share | -2.36 - | -9.35 296.17% | -15.13 61.79% | -15.51 2.46% | -11.90 23.23% | -10.08 15.35% | -9.88 1.92% | -0.01 99.94% | ||
free cash flow yield | -0.02 - | -0.05 223.80% | -0.34 559.83% | -0.25 26.17% | -0.21 17.26% | -0.40 93.02% | -1.67 311.85% | -0.00 99.74% | ||
graham net net | 13.88 - | 34.09 145.60% | 15.44 54.71% | 16.49 6.76% | 24.63 49.40% | 16.54 32.86% | 4.28 74.10% | -0.00 100.02% | ||
graham number | 47.54 - | 121.91 156.43% | 88.20 27.65% | 98.40 11.57% | 105.82 7.54% | 68.71 35.07% | 41.56 39.51% | 0.00 100.00% | ||
income quality | 0.33 - | 0.41 26.83% | 0.63 51.66% | 0.72 15.34% | 0.62 14.10% | 0.81 30.04% | 0.84 3.80% | 0.96 14.24% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 9.90 - | -3.97K 40,240.35% | -3.90K 1.77% | -25.97 99.33% | -14.50 44.15% | -4.45K 30,572.11% | -22.67 99.49% | 11.99 152.87% | ||
interest debt per share | 0.84 - | 0.00 99.43% | 0.00 6.30% | 7.19 161,468.52% | 1.75 75.64% | 0.35 80.06% | 5.04 1,341.35% | -0.00 100.00% | ||
inventory turnover | ||||||||||
invested capital | -0.86 - | 0.01 101.52% | 0.30 - | 0.02 92.47% | 0.02 20.09% | 0.68 3,649.57% | 20.31 2,894.57% | |||
market cap | 257.07M - | 302.78M 17.78% | 79.23M 73.83% | 147.13M 85.70% | 199.07M 35.30% | 145.89M 26.71% | 40.89M 71.97% | 11.62B 28,306.55% | ||
net current asset value | -4.13M - | 24.28M 687.94% | 57.70M 137.68% | 28.77M 50.14% | 41.27M 43.46% | 88.07M 113.40% | 98.94M 12.34% | 32.70M 66.95% | -6.27M 119.18% | |
net debt to ebitda | 2.40 - | 1.12 53.32% | 0.55 50.95% | 1.06 93.39% | 1.70 60.61% | 1.62 4.84% | 0.60 63.18% | 0.08 87.30% | ||
net income per share | -7.24 - | -18.58 156.85% | -17.07 8.17% | -20.03 17.37% | -17.73 11.50% | -10.94 38.30% | -11.44 4.61% | -0.01 99.95% | ||
operating cash flow per share | -2.36 - | -7.69 225.75% | -10.71 39.27% | -13.97 30.41% | -10.64 23.79% | -9.16 13.95% | -9.44 3.02% | -0.01 99.94% | ||
payables turnover | ||||||||||
receivables turnover | ||||||||||
research and ddevelopement to revenue | ||||||||||
return on tangible assets | -0.46 - | -0.49 7.09% | -0.72 45.54% | -0.66 8.58% | -0.57 13.75% | -0.51 9.47% | -0.85 66.74% | -2.91 240.73% | ||
revenue per share | ||||||||||
roe | -0.52 - | -0.52 0.32% | -0.84 61.10% | -0.93 10.67% | -0.63 32.28% | -0.57 9.70% | -1.70 199.05% | -419.53 24,507.17% | ||
roic | 1.33 - | -0.54 140.50% | -0.87 61.87% | -0.69 21.32% | -0.57 16.85% | -0.55 3.25% | -0.95 71.71% | -9.62 913.21% | ||
sales general and administrative to revenue | ||||||||||
shareholders equity per share | 13.88 - | 35.54 156.02% | 20.26 43.00% | 21.48 6.06% | 28.08 30.68% | 19.18 31.67% | 6.71 65.02% | 0.00 100.00% | ||
stock based compensation to revenue | ||||||||||
tangible asset value | -4.13M - | 24.28M 687.94% | 59.83M 146.47% | 36.40M 39.17% | 51.65M 41.92% | 98.44M 90.57% | 112.40M 14.19% | 46.27M 58.83% | 123K 99.73% | |
tangible book value per share | 13.88 - | 35.54 156.02% | 20.26 43.00% | 21.48 6.06% | 28.08 30.68% | 19.18 31.67% | 6.71 65.02% | 0.00 100.00% | ||
working capital | -4.13M - | 24.28M 687.94% | 57.75M 137.89% | 29.51M 48.90% | 55.29M 87.38% | 90.02M 62.81% | 100.89M 12.08% | 63.74M 36.82% | -4.03M 106.31% |
All numbers in (except ratios and percentages)